A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc.
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
Mayo Clinic
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Mirror Biologics, Inc.
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)
Alliance for Clinical Trials in Oncology
Mayo Clinic
Ciusss de L'Est de l'Île de Montréal
Masonic Cancer Center, University of Minnesota
OHSU Knight Cancer Institute
UNC Lineberger Comprehensive Cancer Center
Washington University School of Medicine
Singapore General Hospital
Baylor College of Medicine
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University of Erlangen-Nürnberg Medical School
University of Kentucky
National Cancer Institute (NCI)
Asan Medical Center
M.D. Anderson Cancer Center
Washington University School of Medicine
Baylor College of Medicine
Northwestern University
UNC Lineberger Comprehensive Cancer Center
Accenture
National Institutes of Health Clinical Center (CC)
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center